Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Blackstone Executive Vice Chairman Tony James says he's less optimistic now than before that the U.S.-China trade war could be resolved, but even a smaller deal could help...World Economyread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
President Trump also said he is "not looking for a partial deal" with Beijing, moving away from his suggestion last week that he would consider an "interim deal."Politicsread more
Progress on trade talks will determine how far market will move above new highs.Trader Talk with Bob Pisaniread more
"Sure, the trade war's taking its toll on business ... it's just not taking its toll where it was supposed to," Jim Cramer says.Mad Money with Jim Cramerread more
Joe Biden called on President Donald Trump Friday to release the transcript of a call with a foreign leader that is the subject of a whistleblower complaint. Biden described...Politicsread more
For investors taking a breather from the chaos in August, buckle up as the market is about go crazy again, Goldman Sachs warned.Marketsread more
Palantir Technologies is targeting a valuation of at least $26 billion in a private fundraising round, the first for the Peter Thiel-backed data analytics startup in four...Wall Streetread more
Michael Pack, a conservative filmmaker linked to Steve Bannon, saw at least $1.6 million in donations from his nonprofit sent into the coffers of his independent production...Politicsread more
The New England Patriots released Antonio Brown just 11 days after signing the wide receiver. The NFL Super Bowl champion team initially had kept him in the face of a rape...Sportsread more
Pharmaceutical giant Merck said Tuesday that high consumer demand for its measles vaccines, amid the largest U.S. outbreak in decades, helped boost sales in its second quarter.
Sales of children's vaccines, which includes the New Jersey-based company's MMR vaccine, for measles, mumps and rubella, jumped 58% year over year to $675 million, Merck announced in its second-quarter earnings report Tuesday. Merck, which is the sole U.S. supplier of measles vaccines, said the strong growth was due in part to this year's measles outbreak, which was the largest in the U.S. since 1992.
"There was some buying to the private sector within the U.S. this quarter based on some of the measles outbreaks that you read in the news," Merck Chief Commercial Officer Frank Clyburn said in a post-earnings conference call with investors. "And we do believe that we'll continue to see growth for our pediatric vaccines going forward."
Shares of Merck were up more than 1% in midmorning trading after posting quarterly earnings and revenue that easily beat Wall Street's estimates. The company also narrowed its earnings and revenue forecast for the year due to its $1 billion acquisition of biotech firm Peloton Therapeutics, announced in May.
In May, Merck said it had increased production of the measles vaccine to meet an uptick in demand in the U.S. in the midst of the country's biggest outbreak in decades.
The Centers for Disease Control and Prevention has reported 1,164 individual cases of measles as of July 25. The CDC said the new cases represented a 1.4% increase in the number of cases from the previous week. Officials had officially declared measles eliminated in 2000, but warned that if cases continued to climb this year the U.S. may lose its "eliminated" status.
Before the creation of the measles vaccine in the 1960s, the disease infected an estimated 3 million to 4 million people, hospitalized 48,000 and claimed the lives of between 400 and 500 people annually.
Measles started to spread again in recent years as more parents refused to vaccinate their children, even though health officials stress immunizations are the best way to protect against the measles. The World Health Organization reported a 300% increase in measles cases in the first three months of this year compared with the same time last year.
— CNBC's Angelica LaVito contributed to this report.